Acute Respiratory Infections Clinical Trial
Official title:
Role of Zinc in Recurrent Acute Lower Respiratory Infections
Acute respiratory infections (ARIs) are the most frequent illnesses globally. Despite
advances in the recognition and management ARIs, these account for over 20% of all child
deaths globally.Trace mineral deficiencies have long been implicated in causation and
consequences of many diseases. The importance of adequate zinc intake in human health is
well documented and zinc deficiency is a large public health problem, especially among
children in developing countries.Various studies suggest that zinc-deficient populations are
at increased risk of developing diarrhoeal diseases, respiratory tract infections and growth
retardation.Among the individual interventions zinc supplementation with universal coverage
ranks 5th in preventing under five mortality in India, preceded only in order by breast
feeding; complementary feeding; clean delivery; Hib vaccination; and clean water, sanitation
and hygiene.Numerous studies have examined the association between child mortality and zinc
deficiency. A number of randomized controlled trials evaluating effect of zinc
supplementation have found the intervention to be beneficial in reducing ARI and diarrhoeal
mortality and morbidity but few studies have found beneficial effect in diarrhea and no or
even contrasting effects on morbidity pattern of acute respiratory infections. Whereas role
of zinc in diarrhea is now a well established and specific guidelines and recommendations
have been given for zinc supplementation in diarrhea, role of zinc in acute respiratory
infections is controversial. The contrasting effect of zinc on diarrhoea and acute lower
respiratory infection as reported in several studies is a public health concern, because
zinc supplementation is carried out in many nutrition rehabilitation units. Further in many
of randomized control trials supplement syrups also contained other vitamins, including
vitamin A, known to have effect on respiratory morbidity. Most of the trials evaluating
effect of zinc on respiratory morbidity and mortality are community based and children with
well known causes of recurrent acute lower respiratory infections have not been excluded
from the study pool.
Hence the current study was planned to bridge this gap of information and attempts to detect
the role of zinc using "zinc only preparations" in reducing respiratory morbidity in
children aged 6 to 59 months with recurrent acute lower respiratory infections.
Status | Completed |
Enrollment | 208 |
Est. completion date | July 2008 |
Est. primary completion date | May 2008 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 6 Months to 59 Months |
Eligibility |
Inclusion Criteria: - Children aged 6 to 59 months with documented recurrent acute lower respiratory infection i.e., more than two episodes of ALRI in one year or more than three episodes in any time frame. Exclusion Criteria: - Children with congenital heart diseases - Children with congenital anomalies which can cause recurrent chest infection - Children with Tuberculosis - Children with bronchial asthma or hyperactive airway disease - Children with WZS < -2 of HZS < -2 as per WHO standards - Children with any diarrhoeal episode in past 3 months - Children having receive any zinc supplementation in past 3 months - Children who did not turn up on follow up and could not be contacted were excluded from the study. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
India | Jawaharlal Nehru Medical College, Aligarh Muslim University | Aligarh | Uttar Pradesh |
Lead Sponsor | Collaborator |
---|---|
Jawaharlal Nehru Medical College | Indian Council of Medical Research |
India,
Bhandari N, Bahl R, Taneja S, Strand T, Mølbak K, Ulvik RJ, Sommerfelt H, Bhan MK. Effect of routine zinc supplementation on pneumonia in children aged 6 months to 3 years: randomised controlled trial in an urban slum. BMJ. 2002 Jun 8;324(7350):1358. — View Citation
Bhatnagar S, Natchu UC. Zinc in child health and disease. Indian J Pediatr. 2004 Nov;71(11):991-5. Review. — View Citation
Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet. 2003 Jun 28;361(9376):2226-34. Review. — View Citation
Caufield L, Black R. Zinc deficiency. In: Ezzati M, Lopez AD, Rodgers A, Murray C, eds. Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva, Switzerland: World Health Organization; 2004:257-259
Rahman MM, Vermund SH, Wahed MA, Fuchs GJ, Baqui AH, Alvarez JO. Simultaneous zinc and vitamin A supplementation in Bangladeshi children: randomised double blind controlled trial. BMJ. 2001 Aug 11;323(7308):314-8. — View Citation
Ruel MT, Rivera JA, Santizo MC, Lönnerdal B, Brown KH. Impact of zinc supplementation on morbidity from diarrhea and respiratory infections among rural Guatemalan children. Pediatrics. 1997 Jun;99(6):808-13. — View Citation
Sazawal S, Black RE, Jalla S, Mazumdar S, Sinha A, Bhan MK. Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial. Pediatrics. 1998 Jul;102(1 Pt 1):1-5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change in mean serum zinc level; Number of episodes of ALRI per child ALRI free days per child per year; | six months | No | |
Secondary | Diarrhoeal episodes per child; morbidity free days per child; mean hospitalization days; change in Weight for age and height for age z scores | six months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01731834 -
Pain and Stress Assessment in Children
|
Early Phase 1 | |
Completed |
NCT00377403 -
Treatment of Acute Sinusitis
|
Phase 4 | |
Completed |
NCT02003651 -
Echinacea and Acute Respiratory Illness
|
N/A | |
Completed |
NCT01116076 -
DECISION+, a Training Program to Improve Optimal Drug Prescription
|
Phase 1 | |
Completed |
NCT01918579 -
C Reactive Protein (CRP) Intervention to Reduce Inappropriate Antibiotic Prescriptions in the Primary Healthcare Setting
|
N/A | |
Completed |
NCT02512614 -
Evaluation of Novel Antimicrobial Hand Towels
|
Phase 2/Phase 3 | |
Completed |
NCT02378090 -
A Study to Determine the Causes and Identify Increases in Influenza-Like Illness (ILI) in Mexico
|
N/A | |
Completed |
NCT00851487 -
Trial of Amoxicillin Compared With Placebo for Pneumonia in Children Aged 2-59 Months
|
N/A |